NAD+
Nicotinamide Adenine Dinucleotide / NAD
NAD+ (nicotinamide adenine dinucleotide) is a critical coenzyme present in every living cell, functioning as an essential electron carrier in mitochondrial energy production and as a substrate for sirtuins, PARPs, and CD38 enzymes involved in DNA repair and cellular signaling. Declining NAD+ levels are strongly associated with aging and metabolic dysfunction, making NAD+ repletion a major focus of longevity research. It is administered via IV infusion, subcutaneous injection, or oral precursors (NMN, NR) in anti-aging and neurological research protocols.
Wirkmechanismus
Essential coenzyme present in all living cells. Central to cellular energy metabolism (glycolysis, TCA cycle, oxidative phosphorylation), DNA repair (PARP enzymes), epigenetic regulation (sirtuins), and calcium signaling. Levels decline ~50% between ages 40-60.
Forschungsprotokolle
Nur für Forschungszwecke. Keine medizinische Beratung.
Research protocols use 250-750mg via IV infusion over 2-4 hours. Subcutaneous protocols use 50-100mg daily. Intranasal formulations under investigation. IV sessions typically weekly for 4-8 weeks, then monthly maintenance.
Forschungsnotizen
Clinical Research Status
NAD+ IV therapy is actively studied in clinical trials for conditions including chronic fatigue, neurodegenerative diseases, substance use disorders, and age-related metabolic decline. The precursors NMN and NR have multiple ongoing Phase I/II trials examining bioavailability, safety, and effects on aging biomarkers. While IV NAD+ clinics have proliferated globally, FDA-approved therapeutic indications remain limited to experimental and integrative medicine settings.
Key Published Findings
Research has demonstrated that NAD+ levels decline by approximately 50% between ages 40 and 60, correlating with mitochondrial dysfunction and increased disease susceptibility. Studies in animal models show that NAD+ repletion restores mitochondrial function, improves insulin sensitivity, and extends healthspan markers. Human trials with NR supplementation have confirmed dose-dependent increases in blood NAD+ levels with good tolerability, though functional clinical endpoints are still being validated.
Safety Profile
IV NAD+ infusions are generally well-tolerated but commonly produce transient side effects including chest tightness, nausea, abdominal cramping, and flushing during infusion, which are managed by slowing the drip rate. Oral precursors NMN and NR show excellent safety profiles in clinical doses of 250-1000mg daily with minimal adverse events reported. Theoretical concerns exist about long-term high-dose NAD+ supplementation potentially fueling growth of existing cancers, though clinical evidence for this remains inconclusive.
Drug Interactions & Contraindications
NAD+ may interact with blood pressure medications due to its vasodilatory effects during IV administration. Caution is advised with concurrent use of chemotherapeutic agents, as NAD+-dependent PARP inhibitors may have altered efficacy. Patients with active malignancies should consult their oncologist before beginning NAD+ therapy given the theoretical role of NAD+ in supporting cellular proliferation.
Comparison to Related Compounds
NMN (nicotinamide mononucleotide) is a direct NAD+ precursor requiring one enzymatic step for conversion, offering potentially faster NAD+ elevation than NR. NR (nicotinamide riboside) has more published human clinical trial data and established commercial availability as a supplement (TruNiagen, Elysium). Direct IV NAD+ bypasses the need for enzymatic conversion entirely but requires clinical administration and produces more acute side effects than oral precursors.
Community Observations
Users of IV NAD+ commonly report initial sessions being uncomfortable due to nausea and chest tightness, with subsequent sessions becoming more tolerable as the body adapts. Many practitioners administer loading protocols of 500-1000mg IV daily for 3-5 days followed by monthly maintenance infusions. The biohacking community frequently combines NAD+ protocols with resveratrol and fasting to maximize sirtuin activation and perceived anti-aging benefits.
Halbwertszeit
~45 minutes (IV)
Rekonstitution
Sterile saline for IV; bacteriostatic water for SubQ
Lagerung
Lyophilisiert
Refrigerate 2-8C. Protect from light.
Rekonstituierter
Use within 24 hours of preparation (IV). SubQ: within 7 days.
Rechtsstatus USA
Auch bekannt als
Häufig gestellte Fragen
Was ist NAD+?
NAD+ (nicotinamide adenine dinucleotide) is a critical coenzyme present in every living cell, functioning as an essential electron carrier in mitochondrial energy production and as a substrate for sirtuins, PARPs, and CD38 enzymes involved in DNA repair and cellular signaling. Declining NAD+ levels are strongly associated with aging and metabolic dysfunction, making NAD+ repletion a major focus of longevity research. It is administered via IV infusion, subcutaneous injection, or oral precursors (NMN, NR) in anti-aging and neurological research protocols.
Wie wirkt NAD+?
Essential coenzyme present in all living cells. Central to cellular energy metabolism (glycolysis, TCA cycle, oxidative phosphorylation), DNA repair (PARP enzymes), epigenetic regulation (sirtuins), and calcium signaling. Levels decline ~50% between ages 40-60.
Wie ist der regulatorische Status von NAD+ in den USA?
Supplement (not FDA-regulated as drug)
Wie lang ist die Halbwertszeit von NAD+?
~45 minutes (IV)
Wie wird NAD+ noch genannt?
Nicotinamide Adenine Dinucleotide, NAD
Peptide Contacts bietet wissenschaftliche Zusammenfassungen für informationstechnische Zwecke an. Wir stellen keine Dokumentationen von Anbietern, keine Host- und keine Vertriebsdienstleistungen zur Verfügung und unterstützen keine Anbieter in irgendeiner Weise. Alle Zertifikate der Analyse, GMP-Zertifikate und Kommunikationen mit Anbietern müssen direkt vom Käufer angefordert und überprüft werden. Alles auf dieser Plattform stellt weder rechtliche, medizinische noch berufsmäßige Beratung dar. Nutzer sind allein verantwortlich für die Überprüfung der Anbieterzertifikate und das Gewährleisten des Einhaltens aller anwendbaren lokalen, zuständigen und federalen Gesetze beim Kauf von Forschungschemikalien. Die Nutzung dieser Plattform bedeutet die Annahme volles persönlichen Verantwortlichkeitsbewusstseins.
Ganze Erklärung lesen